Japanese researchers at Toregem BioPharma have developed a drug (TRG035) targeting the USAG-1 protein to potentially regrow teeth. It succeeded in animal tests, and Phase I human trials began in late 2024 at Kitano Hospital for safety assessment. No human results yet; availability hoped for by 2030 if successful. Sources: Popular Mechanics, Snopes, company site.
No comments:
Post a Comment